AVTX vs HPE · P/E 0.0, $51.5M cap vs P/E 20, rev $32.19B
Avalo Therapeutics Inc (AVTX) versus Hewlett Packard Enterprise Co (HPE) — a side-by-side from cached financials, not a winner call.
Avalo Therapeutics Inc (AVTX) is a biotechnology company listed on US.
Hewlett Packard Enterprise Co (HPE) is a communication equipment company listed on US.
Latest reported AVTX revenue for 2025-09-30 was $0. Net income was -$30.6M. AVTX currently screens at market cap $51.5M and trailing P/E 0.0.
Latest reported HPE revenue for 2026-07-31 was $32.19B. Net income was $2.62B. Revenue was up 61.1% from 2026-04-30 to 2026-07-31. HPE currently screens at market cap $27.19B and trailing P/E 19.9.
AVTX currently screens at market cap $51.5M and trailing P/E 0.0. HPE currently screens at market cap $27.19B and trailing P/E 19.9.
Not investment advice. Open the AVTX and HPE stock pages for the full models.
Not investment advice.